Renee Martin

Dr. Martin joined CuraSen in 2020 bringing more than 25 years of experience in the pharmaceutical industry, spanning target assessment through Phase 3 clinical trials in indications from neuroscience through inflammation. Previously, she was Senior Vice President of Medical Sciences at Anthera Pharmaceuticals, responsible for late-stage clinical trials in lupus and exocrine pancreatic insufficiency as well as the enabling nonclinical programs. Prior to her 8-year tenure at Anthera, Dr. Martin spent more than 14 years at Roche Pharmaceuticals in discovery and clinical research.

Dr. Martin received her bachelor’s degree in natural sciences at Cambridge University, UK, and her PhD in pharmacology from King’s College London, UK. She is an author on 24 peer-reviewed publications spanning discovery research through Phase 3 clinical studies.